Insmed

24 sie 2026, 19:56 UTC

Insmed Inc. received approval for Brinsupri in Japan, the first therapy for non-cystic fibrosis bronchiectasis. Shares are lower amid news of a major shareholder's stock sale.

20 sie 2026, 20:02 UTC

Insmed Inc shares are lower amid a significant decline in the Biotechnology sector. Trading volume is unusually high, with no specific news identified.

19 sie 2026, 23:41 UTC

Insmed Inc. shares are higher in after-market trading, reflecting notable volatility with significant fluctuations since Wednesday's close.

17 sie 2026, 20:02 UTC

Insmed shares rise as Duquesne Capital reports $151.9 million stake and Mizuho sets a $192 price target amid ongoing product launches.

14 sie 2026, 19:36 UTC

Insmed Inc shares are lower, reflecting broader market sentiment after a reported decline in retail sales. The stock has closed lower for four consecutive sessions.

13 sie 2026, 19:51 UTC

Insmed shares are lower despite raised earnings estimates and target price increases from HC Wainwright and Wells Fargo during Thursday's session.

12 sie 2026, 19:36 UTC

Insmed shares are trading lower despite multiple analysts issuing positive ratings and target price increases, including BMO's $192.00 and Cantor Fitzgerald's $235.00.

11 sie 2026, 21:16 UTC

Insmed Inc. shares moved slightly lower during after-market hours, remaining near the upper end of their one-month range and above the 20-day moving average.

10 sie 2026, 23:41 UTC

Analysts adjusted price targets for Insmed Inc. after recent evaluations. Shares are higher in after-market trading, reflecting positive sentiment amid these actions.

7 sie 2026, 21:21 UTC

Insmed Inc shares are lower in after-market hours, with no specific news identified for the decline. The stock remains above its 20-day moving average.

6 sie 2026, 23:56 UTC

Insmed Inc shares are trading lower in after-market hours. No specific news was identified to explain the decline.

5 sie 2026, 23:22 UTC

Insmed Inc shares are higher in after-market trading, reflecting positive momentum amid a significant drop in crude oil prices and easing inflation concerns.

3 sie 2026, 19:16 UTC

Insmed Inc shares are lower today, marking the seventh consecutive session of declines. No specific company news was identified to explain the movement.

31 lip 2026, 20:06 UTC

Insmed Inc. shares are lower, continuing a seven-session decline amid rising Treasury yields and crude oil prices, with no specific company news identified.

30 lip 2026, 21:16 UTC

Insmed Inc shares are higher in after-market trading, recovering from earlier losses. The stock rose to a high since Thursday's close.

28 lip 2026, 19:26 UTC

Insmed Inc shares are lower today, with no specific news identified. Broader market sentiment is bearish, influenced by declines in Asian markets.

27 lip 2026, 23:41 UTC

Insmed Inc's shares are higher in after-market hours, rebounding from a lower regular session. No specific news was identified for this price movement.

24 lip 2026, 23:46 UTC

Insmed Inc shares are lower in after-market hours, continuing recent trends. The stock remains near the lower end of its one-month trading range.

22 lip 2026, 19:11 UTC

Insmed shares are lower despite Cantor Fitzgerald's "Overweight" rating and $235 price target, following positive updates on inhalation powder TPIP.

21 lip 2026, 17:41 UTC

BMO Capital initiated coverage on Insmed Inc with an Outperform rating and a $192 price target, contributing to the stock's upward movement.

20 lip 2026, 19:16 UTC

Insmed Inc's shares are lower today amid declines in the Biotechnology sector. Social media highlights positive sentiment around TPIP data and its strong pipeline.